Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Pharm CH 21
Chapter 21: Cholinergic-Blocking Drugs
| Question | Answer |
|---|---|
| 1. The nurse is about to administer a stat dose of intravenous atropine sulfate to a patient who is experiencing a symptomatic cardiac dysrhythmia. During administration of this drug, the nurse will monitor the patient closely for which adverse effect? a. Tachycardia b. Bradycardia c. Ectopic beats d. Cardiac standstill | a. Tachycardia |
| 2. A patient has a prescription for oxybutynin, an anticholinergic drug. When reviewing the patient‘s medical history, which condition, if present, would be considered a contraindication to therapy with this drug? a. Diarrhea b. Hypertension c. Neurogenic bladder d. Uncontrolled angle-closure glaucoma | d. Uncontrolled angle-closure glaucoma |
| 3. The nurse is reviewing the use of anticholinergic drugs. Anticholinergic drugs block the effects of which nervous system? a. Central nervous system b. Somatic nervous system c. Sympathetic nervous system d. Parasympathetic nervous system | d. Parasympathetic nervous system |
| 4. A patient has received an accidental overdose of intravenous atropine. Which drug will the nurse prepare to administer? a. Atenolol b. Bethanechol c. Dicyclomine d. Physostigmine | d. Physostigmine |
| 5. 72 y/o man has a new RX for an anticholinergic drug. He's an active man & enjoys golfing & doing his own yard work. What will the N emphasize to him during the teaching session about his drug therapy? a. Drowsiness may interfere with his outdoor activities. b. Increased salivation may occur during exercise and outside activities. c. Fluid loss may occur as a result of an increased incidence of diarrhea. d. He will need to take measures to reduce the occurrence of heat stroke during his activities. | d. He will need to take measures to reduce the occurrence of heat stroke during his activities. |
| 6. The nurse will monitor for which adverse effect when administering an anticholinergic drug? a. Excessive urination b. Diaphoresis c. Dry mouth d. Pupillary constriction | c. Dry mouth |
| 7. The nurse is reviewing a patient‘s medication history and notes that the patient is taking the cholinergic blocker tolterodine. Which is an indication for this medication? a. Irritable bowel disease b. Induction of mydriasis c. Urge incontinence d. Reduction of secretions preoperatively | c. Urge incontinence |
| 8. A patient has been taking tolterodine, but today her prescriber changed her to a newer drug, darifenacin. What advantage does darifenacin have over the tolterodine? a. The newer cholinergic-blocker drugs are more effective. b. It helps reduce urinary retention. c. It can be used in patients with narrow-angle glaucoma. d. The incidence of dry mouth is much lower with darifenacin. | d. The incidence of dry mouth is much lower with darifenacin. |
| 9. The nurse working in a preoperative admitting unit administers an anticholinergic medication to a patient before surgery. What is the purpose of this drug in the preoperative setting? a. Decrease pain b. Relax the patient c. Reduce urinary frequency d. Reduce oral and gastrointestinal secretions | d. Reduce oral and gastrointestinal secretions |
| 10. In preparation for eye surgery, the nurse monitors for which desired drug effect in a patient who is receiving a cholinergic-blocking eyedrop medication? a. Miosis b. Mydriasis c. Increased intraocular fluid production d. Enhanced tear production | b. Mydriasis |
| 11. A patient has a new prescription for the transdermal form of scopolamine. The nurse knows that this form of scopolamine is used for which condition? a. Angina b. Chronic pain c. Hypertension d. Motion sickness | d. Motion sickness |
| 1. The N is reviewing the indications for atropine sulfate. Atropine is appropriate for which of these Ps? SATA a. A patient who has suddenly developed symptomatic bradycardia with a heart rate of 32 beats/min b. A patient who has suddenly developed symptomatic tachycardia with a heart rate of 180 beats/min c. A patient with severe narrow-angle glaucoma d. A patient who is about to have surgery e. A patient newly diagnosed with myasthenia gravis f. A patient with anticholinesterase inhibitor poisoning | a. A patient who has suddenly developed symptomatic bradycardia with a heart rate of 32 beats/min d. A patient who is about to have surgery f. A patient with anticholinesterase inhibitor poisoning |
| 1. A patient is to receive glycopyrrolate 4 mcg/kg IM 30 minutes before a procedure. The patient weighs 220 pounds; the medication is available in a strength of 0.2 mg/mL. Identify how many milliliters of medication the nurse will draw up into the syringe. | 2 mL |
| Chapter 21: Cholinergic-Blocking Drugs Jamie Garrison | |
| Chapter 19: Adrenergic-Blocking Drugs Jamie Garrison |
Created by:
PRO Teacher
garrisonjr84